
BPC-157/TB-500 (Wolverine)
A combination of BPC-157 and TB-500 peptides that target complementary tissue repair pathways studied in preclinical regenerative research. Premium Research Peptide.
$79.99 – $149.99Price range: $79.99 through $149.99
Verified Test Results
Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory. The report below reflects the identity, purity and full-panel specification data released with this product.
Certificate of Analysis
Purity by HPLC
| Parameter | Result | Method | Specification |
|---|---|---|---|
| Appearance | Good | Visual | Meets spec |
| Purity | 99.52% · Pass | HPLC | ≥ 95% |
| Net Peptide Content | 10.63mg | HPLC | Report |
| Identity | Confirmed | HPLC | Meets spec |
| Fentanyl Screen | Not Detected | Immunoassay | Pass |
| Heavy Metals | Not Detected | ICP-MS | Pass |
| Sterility | No Growth | PCR | Pass |
| Endotoxin | < 0.05 EU/mL | USP <85> | Reported |
Representative report from lot WLV0003 (BPC-157/TB-500 (Wolverine)). Your order ships with its own lot-specific certificate.
View this batch's certificateThird-party verified
Certificate of Analysis
Every lot is HPLC-tested at an ISO/IEC 17025-accredited lab. Open any batch's certificate below.
Wolverine (BPC-157 / TB-500) 10mg
LatestLOT WLV0003
HPLC purity · meets spec
- Labeled
- 10mg
- BPC-157
- 5.42mg
- TB-500
- 5.21mg
- Identity
- Confirmed
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- Jul 30, 2026
8 assays passed · ISO/IEC 17025 accredited
View certificateWolverine (BPC-157 / TB-500) 20mg
LatestLOT WLV0004
HPLC purity · meets spec
- Labeled
- 20mg
- BPC-157
- 10.91mg
- TB-500
- 10.48mg
- Identity
- Confirmed
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- 0.117 EU/mL
- Tested
- Jul 30, 2026
8 assays passed · ISO/IEC 17025 accredited
View certificateWolverine (BPC-157 / TB-500) 10mg
LOT WLV0001
HPLC purity · meets spec
- Labeled
- 10mg
- BPC-157
- 5.32mg
- TB-500/TB-4
- 5.11mg
- Identity
- BPC-157 + TB-500/TB-4
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- May 29, 2026
7 assays passed · ISO/IEC 17025 accredited
View certificateWolverine (BPC-157 / TB-500) 20mg
LOT WLV0002
HPLC purity · meets spec
- Labeled
- 20mg
- BPC-157
- 10.48mg
- TB-500/TB-4
- 10.06mg
- Identity
- BPC-157 + TB-500/TB-4
- Heavy metals
- Not Detected
- Sterility
- No Growth
- Endotoxin
- < 0.05 EU/mL
- Tested
- May 29, 2026
7 assays passed · ISO/IEC 17025 accredited
View certificateCompound Information
Technical specifications
Body Protection Compound-157
Thymosin Beta-4 (Fragment)
Why "Wolverine Stack"?
Stability Information
Handle with care to maintain potency
Sources & References
Peer-reviewed research
BPC-157 and TB-500: Background, Indications, Efficacy, and Safety
McAuley D
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications
Goldstein AL, Hannappel E, Sosne G, Kleinman HK
A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers
Ruff D, Crockford D, Girardi G, Zhang Y
Thymosin beta4 accelerates wound healing
Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
Xu C, Sun L, Ren F, et al.
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair
Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D
BPC-157 enhances growth hormone receptor expression in injured tendon tissue
Staresinic M, Sebecic B, et al.
Progress on the Function and Application of Thymosin β4
Xing Y, et al.
PCO-02 - Safety and Pharmacokinetics Trial (Phase 1)
BPC-157 (200+ studies) and TB-500 (170+ citations) combined research base
⚠️ Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
Frequently asked questions
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.
A seemingly elegant design can quickly begin to bloat with unexpected content or break under the weight of actual activity. Fake data can ensure a nice looking layout but it doesn’t reflect what a living, breathing application must endure. Real data does.
Websites in professional use templating systems. Commercial publishing platforms and content management systems ensure that you can show different text, different data using the same template. When it’s about controlling hundreds of articles, product pages for web shops.